Oct 30, 2017   SOURCE: PR NewsWire

Media Advisory - The Economic Club of Canada: The Life Sciences Industry of Tomorrow: Healthy Canadians, Healthy Future

OTTAWA, Oct. 30, 2017 /CNW/ - What is the true contribution of the innovative pharmaceutical industry to the Canadian economy and R&D investment? What are the potential impacts of federal policy changes aimed at lowering drug prices? Is there a middle ground where Canada is able to lower prices while still retaining its position as a top tier destination for clinical trials and the launch of new innovative medicines? Innovative Medicines Canada President Pamela Fralick and panelists will discuss the results of a Fall 2017 analysis by Ernst & Young about industry's contributions to Canada and how industry and government can work together to enhance affordable, equitable and timely access to new therapies.

The event will be broadcast live over the internet at http://collaboratevideo.net/imc-mnc

Innovative Medicines Canada President Pamela Fralick will be available for media interviews after the event.

    WHO:                      Speakers

                               Pamela C. Fralick:
                               President -
                               Innovative
                               Medicines Canada


                              Moderator
                              Connie Côté, Chief
                               Executive Officer,
                               Health Charities
                               Coalition of
                               Canada


                              Panelists
                              Dr. Bill Cameron,
                               Senior Scientist,
                               Division of
                               Infectious
                               Diseases and
                               Respirology,
                               Medical Director,
                               Clinical Research,
                               Ottawa Hospital
                               Research Institute
                               Ed Dybka, President
                               and CEO -
                               AstraZeneca Canada
                               Inc.


    WHEN:                      Tuesday, October
                               31, 2017 (11:30am-
                               1:30pm)


                              11:15 am               Registration begins

                              12:15 pm               Opening remarks begin

                              12:25 pm               Keynote speech begin

                              12:40 pm               Panel

                              1:10 pm                Q&A

                              1:30 pm                Event concludes


    WHERE:                     Fairmont Chateau
                               Laurier
                               1 Rideau Street,
                               Ottawa
                              Drawing Room

About Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.

SOURCE Innovative Medicines Canada